Inclusion criteria in BE studies [Design Issues]

posted by jag009  – NJ, 2020-05-25 09:43 (1814 d 13:17 ago) – Posting: # 21460
Views: 6,043

Hi,

❝ In BE studies, in case the participants are both males and females, should the ratio between them be 1:1 or any ratio is accepted, also for randomization procedure is there any special requirements in case both included?


You should aim for 1:1 in the protocol but say at least 60:40 split (you can try 70:30 if you are desperate). I do that on my protocols for many yrs and no problem w FDA.

You should randomize w gender as well. I had one CRO who put the first 10 as males and then last 10 as females, lol. No I did not find that funny when I spoke w them.

J

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
134 visitors (0 registered, 134 guests [including 10 identified bots]).
Forum time: 23:01 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5